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Obesity and type 2 diabetes are associated with
mitochondrial dysfunction in adipose tissue, but the
role for adipose tissue mitochondria in the develop-
ment of these disorders is currently unknown. To
understand the impact of adipose tissue mitochon-
dria on whole-body metabolism, we have generated
a mouse model with disruption of the mitochondrial
transcription factor A (TFAM) specifically in fat.
F-TFKO adipose tissue exhibit decreased mtDNA
copy number, altered levels of proteins of the
electron transport chain, and perturbed mitochon-
drial function with decreased complex I activity and
greater oxygen consumption and uncoupling. As a
result, F-TFKO mice exhibit higher energy expendi-
ture and are protected from age- and diet-induced
obesity, insulin resistance, and hepatosteatosis,
despite a greater food intake. Thus, TFAM deletion
in the adipose tissue increases mitochondrial oxida-
tion that has positive metabolic effects, suggesting
that regulation of adipose tissue mitochondria may
be a potential therapeutic target for the treatment
of obesity.
INTRODUCTION
Obesity has reached epidemic proportions worldwide, leading to
numerous comorbidities, including high rates of type 2 diabetes
and metabolic syndrome, accelerated cardiovascular disease,
and increased cancer risk (Haslam and James, 2005). While
reducing caloric intake is the first line of defense against obesity,
an alternative strategy would be to modify the metabolic effi-Cell Mciency and increase energy expenditure in keymetabolic organs,
such as adipose tissue.
The function of both types of adipose tissue, white adipose
tissue (WAT) and brown adipose tissue (BAT), depends on mito-
chondrial activity (Vernochet et al., 2010; Kusminski and
Scherer, 2012). BAT contains numerous mitochondria involved
in fatty acid b oxidation and specifically expresses uncoupling
protein 1 (UCP1), which allows a mitochondrial proton leak,
producing energy expenditure through thermogenesis (Ricquier,
2005). WAT contains fewer mitochondria than BAT, but its mito-
chondria are crucial to adipogenic differentiation (Villarroya et al.,
2009) and are essential to maintain white adipocyte functions,
including normal adipokine secretion (Koh et al., 2007; Kusmin-
ski and Scherer, 2012).
Mitochondrial dysfunction in adipose tissue has been reported
in HIV-1-infected patients undergoing antiretroviral treatment
(Giralt et al., 2011), as well as in obesity, type 2 diabetes, and
the metabolic syndrome (reviewed in Patti and Corvera, 2010).
Mitochondrial DNA (mtDNA) copy number, mitochondrial mass,
and mitochondrial activity are all decreased in the white adipose
tissue of mouse models of obesity, such as ob/ob and db/db
mice (Choo et al., 2006; Rong et al., 2007). In humans, there is
a downregulation of the expression and activity of components
of oxidative phosphorylation (OXPHOS) in white adipose tissue
that correlates with the level of obesity, while a lower mtDNA
copy number is associated with type 2 diabetes (Dahlman
et al., 2006; Kaaman et al., 2007). Themitochondrial dysfunction,
which could impair substrate oxidation in adipose tissue, is
thought to participate in metabolic impairment capacity, thereby
accentuating the development of obesity and associated pathol-
ogies, such as type 2 diabetes.
The major function of mitochondria, and a common area of
dysfunction, is the production of ATP through the mitochondrial
electron transport chain (ETC) and the ATP synthase, which
together are composed of90 proteins that form five complexes
controlling OXPHOS (Gaspari et al., 2004). Thirteen OXPHOSetabolism 16, 765–776, December 5, 2012 ª2012 Elsevier Inc. 765
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Figure 1. Effects of TFAM Knockout on
Mitochondrial Gene and Protein Expression
in White and Brown Adipocytes
(A) TFAM expression was analyzed by western
blot in isolated mitochondria from BAT and white
adipocytes (AF WAT) of Lox and F-TFKO mice at
12 weeks of age. Data are representative of four
samples/genotype; quantification is shown in the
lower panel.
(B and C) TFAM levels and levels of mtDNA-en-
coded mRNAs (B) and mitochondrial DNA copy
number (C) were assessed via qPCR in BAT (upper
panel) and isolated white adipocytes (AF WAT)
(lower panel) from 12-week-old male Lox and
F-TFKO mice (n = 6/genotype).
(D) Mitochondrial morphology of Lox and F-TFKO
BAT by electron microscopy (picture representa-
tive of five mice/group).
Values are given as mean ± SEM. *p < 0.05 versus
respective controls. See also Figure S1.
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minority, are required for proper mitochondrial function. Fatty
acids and pyruvate are metabolized in the mitochondrion to
feed the tricarboxylic acid (TCA) cycle, thereby generating a
gradient of protons, leading to increased mitochondrial mem-
brane potential coupled to the consumption of oxygen. In all
cells, including adipocytes, this energy gradient is then con-
verted into ATP by the F1F0-ATP synthase. In BAT, this energy
gradient can also be converted to heat through the action of
UCP1 (Jastroch et al., 2010).
Mitochondrial transcription factor A (TFAM) is necessary for
mtDNA stability and also initiates mtDNA transcription that
is essential for mtDNA replication and mitochondrial-encoded
gene transcription (Gaspari et al., 2004). Global deletion of
TFAM is embryonically lethal (Larsson et al., 1998), illustrating
the important role of TFAM in mtDNA transcription and
replication.
To better understand the impact of mitochondria on adipose
tissue function, we have selectively disrupted TFAM in brown
and white adipose tissues of the mouse using Cre-lox-mediated
recombination. We find that reduction of TFAM in adipose tissue
increasesmitochondria oxidation capacity due to complex I defi-
ciency and greater uncoupling. The resultant F-TFKO mice are766 Cell Metabolism 16, 765–776, December 5, 2012 ª2012 Elsevier Inc.protected from age- and diet-induced
obesity, glucose intolerance, and hepa-
tosteatosis through increased energy
expenditure.
RESULTS
TFAM Is Efficiently Deleted in Both
the White and Brown Adipose
Tissues in F-TFKO Mice
Mitochondria play an important role in
both brown and white adipose tissue
(Ahima, 2006; Farmer, 2008). As ex-
pected, messenger RNA (mRNA) (Fig-
ure S1A [available online], left panel,)and protein (Figure 1A) for the mitochondrial transcription factor
TFAM was more highly expressed in interscapular BAT than in
subcutaneous inguinal WAT of adult mice. In parallel, BAT also
expressed higher levels of mRNAs for mitochondrially encoded
genes, including mtATP6, mtCytb, and mtCo1 (Figure S1A, right
panel).
To investigate the impact of mitochondrial function in fat, we
created animals with adipose-specific ablation of TFAM by
breeding mice carrying the aP2 promoter-Cre transgene with
mice carrying a floxed TFAM allele that contained loxP sites
surrounding exons 6 and 7 (Larsson et al., 1998). The resultant
aP2-Cre; TFAM f/f (termed fat-specific TFAM KO or F-TFKO)
mice were viable and born at a normal Mendelian ratio, but
exhibited a 5%–10% reduction in body length throughout life
(Figure S1B). DEXA scans at 2 months of age confirmed an
8.5% reduction in femur length and a parallel reduction in lean
body mass that was reflected in individual muscle weights
(Figure S1C).
WAT is composed of white adipocytes, but also other cell
types that comprise the stromal vascular fraction (SVF). Since
white adipocytes contain fewer mitochondria than brown adipo-
cytes and cells of the SVF can contribute significantly to proper-
ties of the whole tissue (Figures S1D and S1E), for most studies
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Figure 2. Ablation of TFAM Protects Mice
from Obesity
(A and B) Body weight of male Lox and F-TFKO
mice upon chow diet (CD) (A) or high-fat diet (HFD)
(B) (n = 6/genotype/diet).
(C and D) Representative sections of BAT and
WAT from 4-month-old Lox and F-TFKO mice on
CD (C) and HFD (D) (stained with hematoxylin and
eosin; pictures were taken at 203).
(E and F) 3H] 2-deoxyglucose uptake (E) and
glycerol release (F) for isolated white adipocytes
from lox and F-TFKO animals at 12 weeks of age
(n = 6/genotype).
(G) 14C-Palmitate oxidation by isolated brown
adipocytes (BA) and white adipocytes (WA) of
10- to 12-week-old lox and F-TFKO mice (n = 6/
genotype).
Values are given as mean ± SEM. *p < 0.05. See
also Figure S2.
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fraction of inguinal WAT (hereafter termed white adipocytes or
AF WAT). Brown adipocytes, on the other hand, are very rich in
mitochondria, and BAT contains fewer SVF cells, so that this
tissue could be studied without cell fractionation. Western blots
revealed a 58% and 81% reduction of TFAM protein in F-TFKO
white adipocytes andBAT, respectively, compared to the control
(Figure 1A). These changes in protein levels were paralleled by
64% and 52% decreases in TFAM mRNA levels analyzed by
quantitative PCR (qPCR) in F-TFKO white adipocytes and BAT
(Figure 1B). Recombination was not efficient in perigonadal fat
at this age (Figure S1F). In inguinal WAT, the knockout was
specific to adipocytes; no differences in TFAM mRNA levels
were found in macrophages isolated from the peritoneal cavity
or from SVF or other major metabolic tissues (Figure S1G).
As a result of the decrease in TFAM, the transcription of
mitochondrially encoded genes, such as mtATP6, mtCytb and
mtCo1, was decreased in both F-TFKO BAT (Figure 1B, upper
panel) and isolated white adipocytes (Figure 1B, lower panel).
Also, mitochondrial DNA copy number was reduced by 55% inCell Metabolism 16, 765–776, DBAT and 76% in the AF-WAT (Figure 1C).
By electron microscopy (EM), mitochon-
dria from F-TFKO BAT displayed irregular
shapes and disrupted cristae, while mito-
chondria from F-TFKO inguinal WAT
showed no apparent abnormalities (Fig-
ure 1D). Morphometry analysis of EM
pictures (Figure S1H) and flow cytometry
analysis of isolated mitochondria (Fig-
ure S1I) revealed a significant increase
in WAT mitochondrial mass in F-TFKO
mice. Furthermore, white adipocyte mito-
chondria were aggregated as shown
by both EM (Figure S1J) and confocal
microscopy (Figure S1K), and occupied
a 2.4-fold greater cytoplasmic area
than in control WAT (Figure S1L). Thus,
aP2-Cre produces efficient TFAM KO
in inguinal WAT and BAT and results
in decreased mtDNA copy number,decreased mitochondrially encoded gene expression, and
altered mitochondrial structure in brown and white adipocytes.
Decrease of TFAM in WAT and BAT Prevents Age- and
Diet-Induced Obesity
To examine adipose tissue mitochondrial function and its conse-
quences on whole-body physiology and metabolism, F-TFKO
mice were studied on both standard chow diet (CD) (22% of
calories from fat) and after exposure to a high-fat diet (HFD)
with 60%of calories from fat fromage2 to 4months. By 4months
of age, F-TFKO mice on CD were 34% lighter than the controls,
a difference in weight significantly greater than the 8%–10%
difference in length and lean mass noted above. Furthermore,
while the control mice gained weight on CD and HFD with age,
F-TFKO mice gained significantly less weight under both dietary
regimes (Figures 2A and 2B). The F-TFKO inguinal WATmass (as
measured by dissection at the time of sacrifice) was decreased
by 48% and 64% on CD and HFD, respectively, while F-TFKO
BAT mass was decreased by 53% on CD (Figure S2A) and
70% on HFD (Figure S2B). The difference remained afterecember 5, 2012 ª2012 Elsevier Inc. 767
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Figure 3. TFAM Deletion in Adipose Tissue
Protects from Insulin Resistance and
Increases Energy Expenditure
(A and B) Glucose levels (A) and serum insulin (B) in
control Lox and F-TFKOmice uponCD andHFD at
4 months of age in the fed state (n = 6–8 animals/
genotype/diet).
(C and D) Intraperitoneal glucose (C) and insulin
tolerance (D) test on Lox and F-TFKO males mice
on CD and HFD at 4 months of age (n = 6–8
animals/genotype/diet).
(E and F) Leptin (E) and adiponectin (F) serum
levels of Lox and F-TFKOmalemice at 4months of
age (n = 6–8 animals/genotype).
(G) Food intake of 2-month-old Lox and F-TFKO
male mice (n = 4 animals/genotype). The entire
experiment was repeated twice.
(H) Oxygen consumption of twomonth old Lox and
F-TFKO male mice (n = 4/genotype). The entire
experiment was repeated twice.
Values are given as mean ± SEM. *p < 0.05 and
**p < 0.01. See also Figure S3.
Cell Metabolism
Fat TFAM-KO Protects against Obesity and Diabetesadjusting for leanmass and body weight (Figure S1B). Reduction
of WAT mass in F-TFKO mice was primarily due to significantly
smaller adipocytes (Figures 2C and 2D) with a decrease in
average cell diameter of 33% on CD and 64% on HFD (Fig-
ure S2C). There was no apparent increase in rates of cell death
or apoptosis as assessed by western blotting for cleaved cas-
pase 3 (Figure S2D) or impaired fat cell differentiation program
(Figures S2E and S2F) and mitochondrial biogenesis (Figures
S2G–S2I), as analyzed by qPCR in F-TFKO WAT and BAT.
Interestingly, mRNA (Figure S2E) and protein levels (Fig-
ure S2J) of the insulin sensitive glucose transporter Glut4 and
hormone-sensitive lipase (HSL) in F-TFKO WAT were higher
than in controls, suggesting potential for greater glucose uptake
and lipolysis. Indeed, we observed a 2-fold increase in basal and
insulin-stimulated 2-deoxyglucose uptake in isolated white
adipocytes from F-TFKO compared to controls (Figure 2E). In
parallel, the lipogenic capacity of F-TFKO white adipocytes
was enhanced (Figure S2K). Basal lipolytic rates were similar
for F-TFKO mice and controls, while isoproterenol-stimulated
lipolysis was increased 36% in the F-TFKO adipocytes (Fig-
ure 2F). Interestingly, 14C-palmitate oxidation was increased by
49% in F-TFKO brown adipocytes and 75% in F-TFKO white
adipocytes compared to their respective controls (Figure 2G).768 Cell Metabolism 16, 765–776, December 5, 2012 ª2012 Elsevier Inc.Increased lipolysis has been associ-
ated with increased macrophage infiltra-
tion and inflammation, but we found no
difference in CD11c, CD68, F4/80, and
IL6 and TNFa expression between
control and F-TFKO WAT (Figures S2L
and S2M). Circulating levels of TNFa
and IL6 were also similar between
F-TFKO and control mice (Figures S2N
and S2O), a further indication that TFAM
KO in adipose tissue does not trigger
adipose tissue and systemic inflamma-
tion. Thus, fat-specific TFAM KO mice
were protected against diet-inducedobesity, and F-TFKO adipocytes remain small with improved
glucose uptake and lipolytic activity consistent with an enhanced
insulin sensitivity state.
Decrease of TFAM in WAT and BAT Prevents
Development of Insulin Resistance and Increase Energy
Expenditure
Consistent with this increased insulin sensitivity, significant
changes in several metabolic parameters were apparent. At
4 months of age, CD- and HFD-fed F-TFKO mice exhibited
a reduction in fasting glucose levels (Figure 3A) and in fed plasma
insulin levels compared to their respective control (Figure 3B).
F-TFKO mice on both the CD (Figure 3C) and HFD (Figure 3D)
showed improved glucose tolerance when compared to appro-
priate controls. F-TFKO mice also exhibited increased insulin
sensitivity after HFD on intraperitoneal insulin tolerance testing
(Figures S3A and 3B). The F-TFKO mice were also protected
from hepatosteatosis. At 4 months of age, the livers of control
mice on HFD were enlarged (Figure S3C) and exhibited gross
lipid accumulation (Figure S3D) and increased triglycerides
content (Figure S3E), whereas the livers of the F-TFKO mice
on HFD were not enlarged and showed no signs of hepatostea-
tosis. By 10 months of age, the body weight differences were
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Figure 4. TFAM Ablation Remodels BAT
and WAT Mitochondria and Increase
Adipose Tissue Oxygen Consumption
(A) Assessment of proteins in the OXPHOS path-
way by western blotting of isolated mitochondria
from BAT and white adipocytes (AF WAT) of
control and F-TFKO mice (8–10 weeks old). Data
are representative of four mice per genotype and
normalized in Figure S4A.
(B and C) F-TFKO and Lox BAT (B) and white
adipocyte (C) isolated mitochondria respiratory
chain enzyme activities were assessed indepen-
dently. Complex I (CPLxI), complex II (CPLxII),
complexes II and III (CPLxII-III), and complex IV
(CPLxIV) (n = 6/genotype) are shown.
(D) Citrate synthase activity in extracts from BAT
and WAT of Lox and F-TFKO mice at 4 months of
age (n = 6/genotype).
(E and F) Oxygen consumption rate (OCR) were
determined in a Seahorse X24 Flux Analyzer with
pieces (10 mg) from BAT (E) and WAT (F) of Lox
and F-TFKO mice under basal (2.5 mM glucose)
and pyruvate (10 mM) loaded conditions.
Data represent the means ± SEM of the OCRs of
10 mg from six adipose tissue pieces/tissue/mice
from n = 6/genotype. *p < 0.05 and **p < 0.01. See
also Figure S4.
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Fat TFAM-KO Protects against Obesity and Diabetesmaintained on both CD and HFD (Figure S3F), while fasting
glucose levels (Figure S3G) and glucose tolerance (Figure S3I)
in the F-TFKO and controls were no longer significantly different.
However, the F-TFKO mice remained more insulin sensitive on
HFD as indicated by a lower insulin level (Figure S3H) and
improved insulin tolerance testing (Figure S3J).
Adipose tissue secretes numerous adipokines, including the
insulin-sensitizing hormone adiponectin and the central regu-
lator of food intake leptin (Klaus, 2004; Friedman, 2009). Interest-
ingly, in the F-TFKO mice, circulating adiponectin levels were
reduced by 44% (Figure 3F) despite greater insulin sensitivity,
whereas, consistent with the small adipocyte size and mass,
circulating leptin levels were decreased by 75% ± 1% (p <
0.01) compared to controls (Figure 3E). Lower circulating adipo-
nectin was unexpected since adiponectin mRNA (Figure S2E)
and intracellular adiponectin protein levels (Figure S2J) were
actually increased in F-TFKO inguinal WAT. This suggested an
alteration in adiponectin secretion and/or processing. Also,Cell Metabolism 16, 765–776, Dcirculating FFA was slightly decreased
in F-TFKO mice on CD in the fed state
but were elevated upon fasting to the
same extend as in controls (Figure S3K).
To better understand how F-TFKO
mice remained lean, wemeasured energy
expenditure in 2-month-old mice using
CLAMS metabolic cages. Despite similar
body weights at this age (Figure S3L), the
F-TFKO mice showed 22% higher food
intake (Figure 3G) and a 10% increase
in oxygen consumption compared to
controls (adjusted per g of leanmass; Fig-
ure 3H). VCO2 was not changed leading
to a decrease in RER (Figure S3M).Thus, the protection against obesity exhibited by F-TFKO mice
was primarily due to increased energy expenditure, and it was
not accompanied by an increase in basal body temperature (Fig-
ure S3N) but rather by a slightly higher sensitivity to short term
cold exposure (Figure S3O), probably to a reduced insulation
and/or reduced BAT mass.
TFAM KO Remodels OXPHOS Function of Adipose
Tissue Mitochondria
To directly characterize the impact of the TFAM KO on adipose
tissue mitochondrial function, we analyzed the relative levels
of mitochondrial- and nuclear-encoded proteins involved in
OXPHOS by western blotting (Figure 4A, quantified in Fig-
ure S4A), mass spectroscopy-based proteomics and func-
tional assays. As expected, there was a 60%–70% decrease
of the mitochondrial-encoded genes cytochrome b (mtCytb)
and mtCo1 in both the F-TFKO BAT and white adipocyte mito-
chondria. While mitochondria from F-TFKO BAT expressedecember 5, 2012 ª2012 Elsevier Inc. 769
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Figure 5. TFAM Ablation Increase Adipose Tissue Metabolic Rate through Increased ETC Flux and Uncoupling
(A) TFAM protein levels were assessed by western blot analysis (upper panel), and mRNA levels were assessed by qPCR (lower panel) in confluent C3H10T1/2
cells (ShSc) and two independent shTFAM knockdown cell lines (shTF1 and shTF2).
(B and C) ATP turnover (B) and proton leak (C) in shTFAM C3H10T1/2 and control cell lines at confluency assessed with a Seahorse Flux Analyzer as described in
the Experimental Procedures.
(D) State 3 respiratory rate of F-TFKO and Lox isolatedmitochondria fromBAT andwhite adipocyte (AFWAT) in presence of malate/pyruvate (complex I) and ADP
from Lox and F-TFKO CD-fed male mice at 10–12 weeks of age (n = 9/genotype).
(E) State 3 respiratory rate of F-TFKO and Lox isolatedmitochondria fromBAT andwhite adipocyte (AFWAT) in presence of Palmitoyl-carnitine/malate (fatty acid)
and ADP from Lox and F-TFKO CD-fed male mice at 10–12 weeks of age (n = 9/genotype).
Cell Metabolism
Fat TFAM-KO Protects against Obesity and Diabetes
770 Cell Metabolism 16, 765–776, December 5, 2012 ª2012 Elsevier Inc.
Cell Metabolism
Fat TFAM-KO Protects against Obesity and Diabetessimilar levels of UCP1 protein as control mitochondria, the
levels of NDUFB8, a representative of complex I (CI), and subunit
1 of complex IV (CIV) were decreased in mitochondria from
F-TFKO BAT and white adipocytes by 77% and 51%, respec-
tively. In contrast, the levels of Atp5A of complex V was
increased in mitochondria from white adipocyte or BAT of F-
TFKO mice compared to control, and succinate dehydrogenase
[ubiquinone] iron-sulfur subunit (SDHB) of complex II was
increased in F-TFKO white adipocytes.
Mass spectroscopic analysis of mitochondria revealed down-
regulation of many nuclear-encoded ETC members in the TFAM
KO BAT (Figures S4B–S4E) except from complex II. When we
grouped the mass spectroscopy results in order to determine
whether there was a systematic downregulation in any group
of the respiratory chain, it appeared that there was a systematic
downregulation of proteins in complex I and complex III, relative
to proteins of the ‘‘other’’ complexes in the respiratory chain (the
results are displayed as ratios in Figure S4F, and the p values are
given in Figure S4G). Further analysis of the enzymatic function
of different ETC complexes confirmed the proteomic data. There
was a 42%–59% decreased activity of complex I (CPLxI) and
a 29%–67% decreased activity of complex IV (CPLxIV) in mito-
chondria of F-TFKO BAT (Figure 4B) and white adipocytes
(Figure 4C). In comparison, activity of complex II (CPLxII) was
actually upregulated in F-TFKO BAT, and activities of complex
II-III (CPLxII-III) were similar in F-TFKO and controls for BAT
and white adipocytes.
Finally, we assessed citrate synthase activity, a key compo-
nent of the TCA cycle, as well as oxygen consumption rates
(OCRs) in control and F-TFKO WAT and BAT. Activity of citrate
synthase (CS) was increased by 18% in F-TFKO BAT and by
46% in WAT compared to control (Figure 4D). Using 10 mg
pieces of WAT and BAT tissues from 2-month-old mice in the
Seahorse Flux Analyzer, we compared very similar control and
F-TFKO adipose tissue in terms of cellular content (Figures
S4H and S4I). F-TFKO BAT basal OCR was increased by
28.4% (692 ± 35 versus 538 ± 36 pM/min) compared to control
BAT in presence of 2.5 mM glucose (Figure 4E), whereas F-
TFKO WAT OCR was doubled compared to that of the control
(486 ± 15 pM/min versus 241 ± 26 pM/min) (Figure 4F). Interest-
ingly, incubation with 10 mM pyruvate increased BAT and WAT
OCR from control mice by 50% ± 10% and 62% ± 13%, respec-
tively, but had little effect on the adipose tissues of the F-TFKO
mice. Furthermore, addition of an FCCP uncoupler increased
OCR to a higher level in control adipose tissue than in F-TFKO
adipose tissue, suggesting that the adipose tissues of the
TFAM KO mouse may already be at their highest metabolic
rate and/or uncoupled (Figure S4J).(F) State 3 respiratory rate in isolated mitochondria from BAT and white adipoc
(complex II) and ADP from Lox and F-TFKO CD-fed male mice at 10–12 weeks o
(G) Respiratory control ratio (RCR) in the presence of complex II substrate in BAT
12 weeks of age (n = 9/genotype).
(H) Analysis of membrane potential based on the accumulation of the TMRE mito
adipocytes of control (Lox) and F-TFKOmale mice. The data are representative of
of n = 6/genotype.
(I) Oxygen consumption rate (OCR) of FACS sorted BAT and white adipocyte
succinate/rotenone and ADP. The data are shown from Lox and F-TFKO CD-fed
Values are given as mean ± SEM, *p < 0.05 and **p < 0.01. See also Figure S5.
Cell MTFAMKO IncreasedMitochondrial Respiratory Capacity
through Decreased Complex I Activity and Increased
Uncoupling
Similar changes were observed using C3H10T1/2 mesenchymal
cell lines with TFAM knockdown (KD, TFAM-shRNA1 [shTF1]
and TFAM-shRNA2 [shTF2]), where TFAM protein was down-
regulated by 61% and 85%, respectively. Indeed, it resulted in
significantly decreased expression of mitochondrial-encoded
genes (Figure 5A, bottom panel), mtDNA content (Figure S5A),
while mitochondrial mass was increased (Figure S5B). ATP turn-
over in these cells, assessed with the Seahorse flux analyzer,
was decreased by 40%–65% (Figure 5B), while a 4-fold increase
in proton leak was observed, indicating greater uncoupling (Fig-
ure 5C). Moreover, reactive oxygen species (ROS) levels were
increased in TFAM KD cell lines (Figure S5C), and it was suffi-
cient to cause a significant increase in lipid peroxidation,
a monitor of oxidative damage (Figure S5D).
To dissect the mechanism by which TFAM KO leads to
increased oxygen consumption, we examined the metabolic
capacity of F-TFKO isolated mitochondria using different
substrates in presence of ADP (State3) and inhibitors: complex
I (malate/pyruvate) and complex II (succinate/rotenone) or fatty
acids, such as palmitoyl-carnitine). We also measured state 4,
which represents oxygen consumption not linked to ATP
synthesis, i.e., respiration due to uncoupling. In the presence
of complex I substrates, no difference in state 3 OCR was de-
tected between F-TFKO and control mitochondria (Figure 5D),
whereas in the presence of fatty acids, state 3 OCR was signifi-
cantly higher in F-TFKO compared to control for mitochondria
from both BAT and white adipocytes (Figure 5E). Moreover, in
presence the of complex II substrate, OCR was also increased
in BAT and white adipocyte mitochondria from F-TFKO mice
by 49% and by 75%, respectively (Figure 5F), demonstrating
increased metabolic flux and respiratory capacity despite
concomittant complex I dysfunction. Thus, in TFAM KO mito-
chondria, respiratory function has shifted and relies primarily
on complex II function. Calculation of respiratory control ratio
(RCR = state 3 / state 4), an index of mitochondrial coupling, re-
vealed that in F-TFKO BAT and white adipocyte mitochondria,
RCR was slightly but significantly lower than in controls and
demonstrated an intrinsic chronic uncoupling (Figure 5G).
TFAM deletion triggered a greater proton leak that did not rely
on UCP1 in BAT, since a lower RCR was maintained despite
GDP competition (Figure S5E).
Moreover isolated mitochondrial function was assessed by
flow cytometry with the accumulation of the potential-sensitive
mitochondria-specific dye TMRE. Mitochondria from F-TFKO
BAT and white adipocytes accumulated significantly less TMREytes (AF WAT) in the presence of Succinate/Glycerol-3-phosphate/rotenone
f age (n = 9/genotype).
and white adipocytes (AF WAT) from Lox and F-TFKO CD-fed male mice at 10–
chondrial dye by FACS of isolated mitochondria from BAT and isolated white
the basal state and oligomycin treatment and are shown as themedians ± SEM
mitochondria were measured with a Seahorse Flux Analyzer in presence of
male mice at 10–12 weeks of age (n = 6/genotype).
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inhibitor, further supporting the idea of a greater proton leak in
adipocytes mitochondria upon TFAM KO (Figure 5H). Sorting
allowed us to select and to compare the oxygen consumption
rate of only MitoTracker green/TMRE-positive mitochondria
and remove potential debris that might contribute to protein
content. In the presence of complex II substrate, state 3 OCR
of F-TFKO BAT and WAT mitochondria drastically increased by
79%± 19% and 210%± 39% respectively (Figure 5I), consistent
with increased oxidative function. The combination of increased
tissue, cellular, andmitochondrial oxygen consumption rates and
reduced RCR and TMRE accumulation after oligomycin treat-
ment clearly indicates a greater oxidation rate and uncoupling
from F-TFKO adipose tissues mitochondria.
Effects of TFAM Reduction on Adipose Tissues
Metabolites
To complete the characterization of F-TFKO adipose tissue,
we conducted measurements of lipid and DNA oxidative
damage, as well as metabolomic profiling of organic acids
and acyl carnitines using a quantitative mass spectroscopic
approach. As shown in Figures 6A and 6B, increased lipid
peroxidation (TBARS) and oxidative DNA damage (8-hydroxy-
deoxyguanosine or 8OHdG) are both observed within F-TFKO
WAT and BAT only upon HFD feeding and not in CD feeding
condition (Figures S6A and S6B).
Metabolomic analysis revealed increased levels of almost all
Krebs cycle intermediates in BAT from F-TFKO (Figure S6C)
and of pyruvate and lactate, changes most commonly associ-
ated with an increased glycolysis. Fatty acid profiling of BAT
and WAT revealed higher levels of multiple acyl carnitines in
the F-TFKO BAT (Figure 6C) and F-TFKOWAT (Figure 6D). Short
(S) and medium chain (MC) acyl carnitines were upregulated in
F-TFKO BAT, whereas several long (L) and very long (VL) chain
acyl carnitines were specifically increased in adipose tissue of
F-TFKO mice independent of the nutritional status. This may
be related to altered peroxisome biogenesis with decreased
expression of PEX3 and PEX19 or function with the downre-
gulation of b-ketothiolase enzyme (Figure S6D). This is further
suggested by changes in peroxisome aggregation in white
adipocytes (Figure S6E). Interestingly, a subset of these acyl
carnitines, including C6, C8, C10, C10-OH/C8-DC, and C22:4
in fed F-TFKO BAT and C5:1, C8:1-OH/C6:1-DC, C10:2, C7-
DC, and C8:1-DC in fed F-TFKO WAT were also increased in
control mice upon fasting (Figures 6E and 6F), suggesting they
may be linked to higher rates of lipolysis. Finally, while this set
of acyl carnitines was upregulated in F-TFKO BAT either in fed
or fasted state, it was comparable in F-TFKO fasted WAT to
control fed WAT indicating a unique adaptation of WAT to
TFAM deletion. Thus, TFAM deletion in adipose tissues results
in remodeling of the OXPHOS process and changes in glycolysis
and lipid oxidation with increased ETC flux and uncoupled respi-
ration, giving rise to more metabolically active adipose tissue
(Figure 7).
DISCUSSION
At the whole-body level, proper mitochondrial function is
required for normal metabolism and health (Trifunovic et al.,772 Cell Metabolism 16, 765–776, December 5, 2012 ª2012 Elsevier2004; Lane, 2006). Studies of genetic diseases associated with
mitochondrial dysfunction has revealed variability in the meta-
bolic consequences. In general, phenotypic and biochemical
mitochondrial dysfunction are observed only when some
threshold is exceeded (Rossignol et al., 2003), indicating that
mitochondria are more adaptable to alterations in ETC function
than previously thought. Consequences of TFAM deletion on
cell function are tissue specific, ranging from absence of a
phenotype for epidermal progenitor cells (Baris et al., 2011)
to drastic alteration of cellular viability and function for cells
that rely highly on oxidative function (Silva et al., 2000; Wreden-
berg et al., 2006; Wang et al., 1999; Sterky et al., 2011). In the
present study, we have found that reduction of TFAM in adipose
tissue of mice reduces mtDNA copy number and results in re-
modeling of the ETC through downregulation of multiple proteins
involved in oxidative phosphorylation. As a result, and somewhat
surprisingly, F-TFKOmice exhibit higher energy expenditure and
are protected from age- and diet-induced obesity, insulin resis-
tance, and hepatosteatosis.
Inactivation of TFAM in BAT and WAT results in decreased
complex I and IV enzymatic activity, which is similar to changes
observed in heart and skeletal muscle following tissue-specific
TFAM KO (Wang et al., 1999; Wredenberg et al., 2006). Although
the association of complex IV dysfunction with normal or even
increased mitochondrial respiratory function appears paradox-
ical, similar findings have been reported in other situations (Letel-
lier et al., 1994; Kunz et al., 1999; Dell’agnello et al., 2007). It is
thus likely that F-TFKO complex IV activity is below the threshold
to produce failure of the ETC. In our system, complex I enzymatic
activity is also significantly decreased in F-TFKO BAT and WAT.
To compensate, ETC flux is increased in presence of complex II
substrates. This is in accordance with previous human studies
showing that reduction of complex I activity increased oxidative
capacity in the presence of complex II substrate (Hoppel et al.,
1987) and increased fatty acid oxidation (Roef et al., 2002).
Finally, patients with isolated complex I deficiency (CID) in skel-
etal muscle mitochondria have increased whole-body oxygen
consumption at rest (Roef et al., 2002). TFAM deletion in adipose
tissue results in a similar effect, with a shift from complex I- to
complex II-dependent respiratory function and an increase in
citrate synthase activity and basal respiratory capacity.
Moreover, in vitro knockdown of TFAM increases mitochon-
drial membrane proton leak. The decreased RCR in isolated
mitochondria from F-TFKO mice further confirmed a chronic
and moderate uncoupled state of mitochondria from adipose
tissues triggered by TFAM deletion in vivo. It is difficult to define
how much uncoupling and increased flux contributes to the
increase in oxygen consumption in the F-TFKO mice because
they exhibit a shift from complex I to II driven respiration.
However, based on our results, it is clear that increasing mito-
chondrial oxidation in fat has positive metabolic effects that
protect mice from obesity and insulin resistance, despite lower
circulating adiponectin levels and increased adipose tissue
oxidative stress.
Dysregulation of electron transport chain function is present
in many insulin resistant states, including type 2 diabetes and
obesity (Keller and Attie, 2010). In humans, downregulation of
OXPHOS genes in skeletal muscle is associated with insulin re-
sistance (Patti et al., 2003). Impairment of mitochondrialInc.
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Figure 6. Adipose Tissue Metabolic Status upon TFAM KO
(A and B) Lipid peroxidation was measured by a TBARS assay (A) and oxidative DNA damage was measured by an 8 Hydroxy-2-deoxy guanosine (8-OHdG)
assay (B) in BAT and WAT from F-TFKO and Lox HFD-fed mice. The data are represented as fold induction compared to their respective control adipose tissue
(n = 6/genotype).
(C and D) Sets of Acyl carnitine levels specifically upregulated in F-TFKO BAT (C) andWAT (D) as assessed by metabolomic analysis in both fed and 24 hr fasting
state. Data are shown relative to Lox control fed state (n = 5/genotype).
(E and F) Acyl carnitine levels in control and F-TFKO BAT (E) and WAT (F) were analyzed by metabolomic analysis in fed and 24 hr fasting state. Data are shown
relative to Lox control fed state (n = 5/genotype).
Asterisks indicate a significant difference in all panels (*p < 0.05). See also Figure S6.
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Figure 7. Schematic of Changes inMitochondria of F-TFKO Adipose
Tissue
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Fat TFAM-KO Protects against Obesity and Diabetesbiogenesis (Handschin et al., 2007a, 2007b; Vianna et al., 2006)
leads to abnormal glucose homeostasis. Conversely, increased
mitochondrial biogenesis in skeletal muscle has been reported
to protect mice against diet-induced obesity and insulin
resistance (Attane´ et al., 2012; Chen et al., 2010). However,
skeletal muscle TFAM KO (Wredenberg et al., 2006) or AIF KO
(Pospisilik et al., 2007) mice have improved glucose tolerance,
similar to adipose-specific TFAM deletion. In both models,
complex I and complex IV activity are downregulated andmutant
mice are protected from obesity even upon HFD feeding and
remain insulin sensitive.
The metabolomic analysis adds another dimension to the role
of normal mitochondrial function in adipose tissue. This revealed
an accumulation of pyruvate and lactate in F-TFKO BAT consis-
tent with increased glycolysis. Similar effects are seen in heart
after TFAM KO, as a metabolic switch triggers greater rates of
glycolysis, probably as the result of insufficient ATP production
from oxidative phosphorylation (Hansson et al., 2004). In terms
of fatty acid metabolism, F-TFKO adipocytes have increased
FA oxidation capacity, but there is also an upregulation of two
specific sets of acyl carnitines—one which mirrors the effects
of fasting and one which is independent of fasting—giving
TFAM KO adipose tissue a unique metabolic signature.
Strategies to combat obesity and improve insulin sensitivity
include increasing BAT mass and/or activity and ‘‘browning’’ of
white adipose tissue (Cao et al., 2011; Bostro¨m et al., 2012;
Fisher et al., 2012; Bordicchia et al., 2012; Vernochet et al.,
2010). The latter is a term used to describe an increase in mito-
chondrial number and induction of BAT markers, such as UCP1,
Cidea, and diodinase 2, in WAT (Tseng et al., 2010). Another
approach to combat obesity and improve insulin sensitivity
would be to increase energy expenditure of white adipose or
other tissues by promoting futile cycle activity through enhanc-774 Cell Metabolism 16, 765–776, December 5, 2012 ª2012 Elseviering uncoupled respiration (Harper et al., 2008; Colman, 2007;
De Pauw et al., 2009). This raises the possibility of developing
safer chemical uncouplers that could be used to treat obesity
by increasing mitochondrial oxidation rates either by lowering
the coupling efficiency and/or increasing ETC flux through
complex 1 deficiency. Interestingly, TZDs and Metformin have
been shown to inhibit complex I activity (Brunmair et al., 2004),
and both of them are used for the treatment of type 2 diabetes
as they improve glucose metabolism. Whether agents that
reduce levels of TFAM in adipose tissue could be another
possibility remains to be determined, but regulation of mito-
chondrial function in adipose tissue and/or muscle may be a
potential therapeutic target for the treatment of obesity and
type 2 diabetes.EXPERIMENTAL PROCEDURES
Animals and Diets
aP2-Cre transgenic (Abel et al., 2001) and TFAM-floxed (TFAMf/f) mice (Lars-
son et al., 1998) have previously been described. Animal care and study proto-
cols were approved by the Animal Care Committee of Joslin Diabetes Center.
Maintenance of mice is described in detail in the Supplemental Experimental
Procedures.
Body Composition and Metabolic Analysis
Body composition was measured with a Lunar PIXImus2 densitometer (GE
Medical Systems). Activity was measured with the OPTO-M3 sensor system
(Comprehensive Laboratory Animal Monitoring System [CLAMS], Columbus
Instruments). Indirect calorimetry was measured on the same mice with an
open-circuit Oxymax system (Columbus Instruments). For metabolic cage
analysis, two separate groups of mice were utilized. The first group was
composed of 2-month-old mice fed a chow diet ad libitum (seven F-TFKO
and six control Lox). The second group was composed of seven 5-month-
old F-TFKO and eight control mice fed either a chow diet or high-fat diet ad
libitum (starting 6 weeks of age). The detailed methods and calculation are
described in the Supplemental Experimental Procedures.
Intraperitoneal glucose (2 g/kg weight) and insulin tolerance (1.25 unit/kg)
tests were performed after a 16 hr and 4 hr fasting period, respectively. Insulin,
free fatty acids, leptin, and adiponectin were measured by ELISA (Crystal
Chem). Further details can be found in the Supplemental Experimental
Procedures.
Cell Culture
Tfam was stably knocked down in C3H10T1/2 cells by short hairpin RNA
(shRNA) delivered by lentiviral infection. Target sets consisting of two separate
shRNA (shTF1 and shTF2) sequences for each gene cloned into pLKO.1. A
pool of shRNA against TFAM (RMM4534-NM_009360), as well as shSCR in
pLKO.1, was purchased from Open Biosystems. Cell culture procedures can
be found in the Supplemental Experimental Procedures.
Analysis of Gene Expression by Quantitative PCR
Total RNA was isolated with an RNeasy minikit (QIAGEN), and complemen-
tary DNA (cDNA) was synthesized with the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems). The gene expression method was
determined by RT-qPCR performed on an ABI Prism 7900HT sequence
and is provided, with primers sequences, in the Supplemental Experimental
Procedures.
Adipocyte Isolation and Analysis
Inguinal WAT and interscapular BAT from mice either fed a chow diet for
20 weeks or a HFD for 14 weeks (started at 6 weeks of age) (n = 4/group)
were fixed in 10% formalin and embedded in paraffin and stained with
hematoxylin and eosin. Adipocyte diameters were calculated with Image J
software.Inc.
Cell Metabolism
Fat TFAM-KO Protects against Obesity and DiabetesAdipocyte isolation, glucose uptake, lipogenesis, lipolysis, and fatty acid
oxidation were measured from 10- to 12-week-old control (Lox) and F-TFKO
mice and are detailed in the Supplemental Experimental Procedures.
Confocal Microscopy, Electron Microscopy, and Morphometric
Analysis
White adipocytes from F-TFKO and control mice were isolated and mitochon-
dria were labeled with the mitochondria-specific dyes with MitoTracker Green
from Molecular Probes (15 nM) for 30 min. Technical and quantification
methods can be found in the Supplemental Experimental Procedures.
Western Blot Analysis
Proteins were extracted from total tissues or isolated mitochondria from white
adipocytes and BAT and homogenized in 13 RIPA buffer containing 0.1%
SDS. Uses of various antibodies used for immunoblotting and quantification
are described in detail in the Supplemental Experimental Procedures.
Mitochondrial Analysis
F-TFKO and control mitochondria from inguinal white isolated adipocytes and
interscapular BAT were isolated, analyzed by flow cytometry, and sorted for
further assessment of their bioenergetic profiles (state 3 and RCR). Proteomic
analysis and ETC activity are also further described in the Supplemental
Experimental Procedures.
Oxidative Damage
Thiobarbituric acid reactive substances (TBARS) and 8-hydroxy-2-guanosine
(8-OH-dG) methods are described in the Supplemental Experimental
Procedures.
Metabolomics and Lipid Analysis from Tissue and Plasma
Control and F-TFKO mice were subjected for 6 weeks to a HFD beginning
6 weeks of age. Mice were subjected or not to a 12 hr fasting before being
sacrificed. Acylcarnitines and organic acids were analyzed as described in
the Supplemental Experimental Procedures.
Cellular and Tissue Metabolic Rate
Cellular and adipose tissue bioenergetics profile are described in details in the
Supplemental Experimental Procedures.
Triglycerides Quantification
Liver triglyceride content was determined with the Triglyceride Colorimetric
Assay kit (Cayman Chemical, Ann Arbor, MI) from 4-month-old male mice on
CDorHFD.Details are provided in theSupplemental Experimental Procedures.
Statistics
Data are expressed as means ± SEM unless otherwise indicated. All differ-
ences were analyzed by a Student’s t test. Results were considered significant
if either *p < 0.05 or **p < 0.01.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2012.10.016.
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